Key result
Mechanism-driven management targets recurrent cardioembolic stroke in young adults amid limited quantitative trial evidence.
Why the study?
Cardioembolic stroke in young adults involves distinct aetiologies and carries a disproportionate lifetime burden, yet management evidence relies heavily on extrapolation from older populations and age-specific findings remain lacking.
This narrative review highlights the need for mechanism-driven, individualized diagnostic and management strategies to reduce recurrent cardioembolic stroke risk in young adults, given that current evidence largely relies on extrapolation from older populations.
May support mechanism-driven prevention in young adults; leaves open validation via age-specific prospective trials.
Cardioembolic stroke is a major cause of ischaemic stroke, arising from emboli of cardiac origin and carrying a substantial risk of recurrent events. In young adults, ischaemic stroke is less common than in older populations but is associated with a disproportionate lifetime burden of disability and mortality. The aetiological profile of this group is relatively different from older patients, with a higher contribution by cardioembolic and non-atherosclerotic factors, including structural cardiac abnormalities, occult atrial fibrillation (AF), and patent foramen ovale (PFO)(Ohya et al. 2022). This narrative review examines the major aetiologies of cardioembolic stroke in young adults, with a focus on cardiovascular pathophysiology and management. Clinical recognition challenges are identified as presenting characteristics are frequently nonspecific and insufficient to adequately differentiate cardioembolic stroke from other ischaemic subtypes. (Marcoff and Homma 2014). This review will discuss diagnostic strategies such as electrocardiography, cardiac imaging, and prolonged rhythm monitoring (Stack and Cole 2017). Management and secondary prevention strategies are discussed, however much of the available evidence relies on extrapolation from older populations. While advances in diagnosis and risk stratification have increased detection of cardioembolic causes, age-based findings are still lacking to assist in determining the best management strategies (Bukhari et al. 2023). This review discusses the importance of mechanism-driven individualised approaches to reduce recurrent stroke risk for cardioembolic ischaemic stroke in young adults.
No takes yet. Share an insight, caveat, or question.
Thwe et al. (2026) conducted a review in Cardioembolic stroke. Mechanism-driven individualised diagnostic and secondary prevention strategies was evaluated on Recurrent stroke risk. Mechanism-driven individualised management is emphasized to reduce recurrent cardioembolic stroke in young adults, as current evidence relies on older populations without quantitative trial data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: